BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23944618)

  • 1. Therapy of melanocytic conjunctival tumors.
    Halas JM; Svetlosakova Z; Babal P
    Bratisl Lek Listy; 2013; 114(8):446-50. PubMed ID: 23944618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of pigmented conjunctival lesions.
    Oellers P; Karp CL
    Ocul Surf; 2012 Oct; 10(4):251-63. PubMed ID: 23084146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding of conjunctival melanocytic pigmented lesions within pterygium.
    Perra MT; Colombari R; Maxia C; Zucca I; Piras F; Corbu A; Bravo S; Scarpa A; Sirigu P
    Histopathology; 2006 Mar; 48(4):387-93. PubMed ID: 16487360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
    Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
    Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
    Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo confocal microscopy of pigmented conjunctival tumors.
    Messmer EM; Mackert MJ; Zapp DM; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1437-45. PubMed ID: 16598465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival nevus and melanoma.
    Furdova A; Pesko K; Strmen P; Kobzova M
    Bratisl Lek Listy; 2007; 108(7):287-91. PubMed ID: 17972544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigmented conjunctival and scleral lesions.
    Liesegang TJ
    Mayo Clin Proc; 1994 Feb; 69(2):151-61. PubMed ID: 8309267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
    Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
    Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
    LeBlanc RE; Miller DM; Zegans ME
    J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Focus on clinical and pathological management of conjunctival melanocytic tumors].
    Lassalle S; Caujolle JP; Leger F; Maschi C; Gastaud L; Nahon-Esteve S; Thariat J; Baillif S; Hofman P
    Ann Pathol; 2018 Jun; 38(3):153-163. PubMed ID: 29803361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
    Finger PT; Czechonska G; Liarikos S
    Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current appraisal of conjunctival melanocytic tumors: classification and treatment.
    Harooni H; Schoenfield LR; Singh AD
    Future Oncol; 2011 Mar; 7(3):435-46. PubMed ID: 21417906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
    Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
    Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic conjunctival tumors.
    Kurli M; Finger PT
    Ophthalmol Clin North Am; 2005 Mar; 18(1):15-24, vii. PubMed ID: 15763188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant melanoma of the conjunctiva].
    Novais GA; Karp CL
    Arq Bras Oftalmol; 2012; 75(4):289-95. PubMed ID: 23258665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spontaneous changes in pigmentation in a conjunctival nevus].
    Gornig H
    Klin Monbl Augenheilkd; 1984 Jan; 184(1):46-7. PubMed ID: 6708387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.